Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Nebivolol

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,505Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of December 25, 2024
    Enforcement Report - Week of December 25, 2024

    25 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-25-2024-24704.pdf

    FDA
    25 Dec 2024
    Share Share
    MSN`s Generics Nebivolol HCl Receives Approval in US
    MSN`s Generics Nebivolol HCl Receives Approval in US

    01 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217397

    FDA
    01 Oct 2024
    Share Share
    Mankind's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Mankind's Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    14 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216172

    FDA
    14 Nov 2022
    Share Share
    Prinston's Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.
    Prinston's Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.

    19 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210596

    FDA
    19 Sep 2022
    Share Share
    ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results
    ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results

    08 Aug 2022

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20220808005200/en

    BUSINESS WIRE
    08 Aug 2022
    Share Share
    PRINSTON 's Generic Nebivolol Hydrochloride Receives Approval in US
    PRINSTON 's Generic Nebivolol Hydrochloride Receives Approval in US

    07 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212682

    FDA
    07 Apr 2022
    Share Share